SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-126758
Filing Date
2021-10-15
Accepted
2021-10-15 16:18:23
Documents
54
Period of Report
2021-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tmb-20210831x10q.htm   iXBRL 10-Q 1336642
2 EXHIBIT 31.1 tmb-20210831xex31d1.htm EX-31.1 12766
3 EXHIBIT 32.1 tmb-20210831xex32d1.htm EX-32.1 6479
  Complete submission text file 0001104659-21-126758.txt   5228882

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tmb-20210831.xsd EX-101.SCH 43177
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tmb-20210831_cal.xml EX-101.CAL 30761
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmb-20210831_def.xml EX-101.DEF 209567
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20210831_lab.xml EX-101.LAB 361333
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20210831_pre.xml EX-101.PRE 301530
9 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20210831x10q_htm.xml XML 752173
Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 000-55535 | Film No.: 211326274
SIC: 2834 Pharmaceutical Preparations